No-Fuss Transgene Delivery

Targeted retroviral delivery of DNA is effective but hard to control, and can often prove cytotoxic due to insertional mutagenesis.

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Targeted retroviral delivery of DNA is effective but hard to control, and can often prove cytotoxic due to insertional mutagenesis. Now Christopher Baum of the Cincinnati Children's Hospital Research Foundation and colleagues have devised a retrovirus-based delivery system that circumvents this problem.1

The team generated mouse leukemia virus-based vectors in which the retroviral primer-binding site was disabled. "They just contain mRNA," Baum says. "They enter the cell but do not initiate the key aspect of the retroviral life cycle, reverse transcription." Thus, host DNA remains untouched. Instead, the mRNA (in this case, encoding Cre recombinase) is immediately translated into protein, a process called retroviral pseudotransduction.

"People had usually thought the mRNA useless when not converted to DNA in the target cell," Baum says. "The efficiency of this shortcut ... is sufficient to express proteins that can exert a drastic effect, even when being expressed for very short periods of time."

...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Charles Choi

    This person does not yet have a bio.

Published In

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio
Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio